In Stock
Pemetrexed Injection IP
Pemetrexed Injection IP is an anticancer medicine used in the treatment of certain types of lung cancer and mesothelioma.
Product Details
Pemetrexed Injection IP contains pemetrexed, an antifolate anticancer medicine used in combination with other treatments for certain types of non-small cell lung cancer and malignant pleural mesothelioma. It interferes with folate-dependent processes that cancer cells require for DNA and RNA production, thereby helping slow cancer cell growth.
Key Benefits
- Used in the treatment of certain non-small cell lung cancers
- Used for malignant pleural mesothelioma in appropriate patients
- Helps inhibit the growth and multiplication of cancer cells
- May be used as part of combination chemotherapy
- Supports targeted management of specific cancers under oncology care
How It Works
Pemetrexed inhibits several enzymes involved in folate metabolism and the production of DNA and RNA. This reduces the availability of substances needed for cancer cell division and growth, helping slow the progression of certain tumors.
Common Side Effects
- Fatigue
- Nausea
- Vomiting
- Loss of appetite
- Constipation
- Diarrhea
- Skin rash
- Mouth sores
- Changes in blood cell counts
Important Information
Pemetrexed Injection IP should be administered under the supervision of a qualified oncologist or healthcare professional. Blood counts and kidney function are generally monitored during treatment. Folic acid and vitamin B12 supplementation are commonly used with pemetrexed to reduce treatment-related toxicity, as directed by the oncologist. Inform your doctor about kidney problems, other medical conditions, and all medicines you are taking. Seek medical attention for fever, unusual bleeding, severe skin reactions, breathing difficulties, or signs of infection.
